Literature DB >> 24072330

Procalcitonin kinetics: a reliable tool for diagnosis and monitoring of the course of bacterial infection in critically ill patients with autoimmune diseases.

Yan Shi1, Xi Rui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072330     DOI： 10.1007/s00134-013-3103-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol.

Authors:  Cristina Danés; Julián González-Martín; Tomàs Pumarola; Ana Rañó; Natividad Benito; Antoni Torres; Asunción Moreno; Montserrat Rovira; Jorge Puig de la Bellacasa
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis.

Authors:  Jiunn-Yih Wu; Si-Huei Lee; Chih-Jung Shen; Yueh-Che Hsieh; Ping-Hsiung Yo; Hsiang-Yun Cheng; Rai-Chi Chan; Chien-Chang Lee; Shy-Shin Chang
Journal:  Arthritis Rheum       Date:  2012-09

3.  Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.

Authors:  J P Lanoix; A M Bourgeois; J Schmidt; J Desblache; V Salle; A Smail; J C Mazière; F Betsou; G Choukroun; P Duhaut; J P Ducroix
Journal:  Lupus       Date:  2010-10-11       Impact factor: 2.911

4.  Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.

Authors:  R Brunkhorst; O K Eberhardt; M Haubitz; F M Brunkhorst
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

5.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889
  5 in total
  2 in total

1.  The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.

Authors:  Yan Shi; Jin-min Peng; Xiao-yun Hu; Yao Wang
Journal:  BMC Anesthesiol       Date:  2015-10-07       Impact factor: 2.217

2.  Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.

Authors:  Chou-Han Lin; Song-Chou Hsieh; Li-Ta Keng; Ho-Sheng Lee; Hou-Tai Chang; Wei-Yu Liao; Chao-Chi Ho; Chong-Jen Yu
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.